Prime Medicine, Inc. Common Stock
PRME •
Sell Closed
Signal type
Sell
Status
Closed
Open Price
$3.29
Closed Price
$3.70
Performance
-12.46%
Days Open
18
Signal Setup
Signal Type Sell
Status Closed
Open Date Mar 27, 2026
Open Price $3.29
Stop Loss $4.15
Timespan Day
Trade Outcome
Closed Status Loss
Closed Date Apr 14, 2026
Closed Price $3.70
Performance -12.46%
Days Open 18
Company Profile
Name Prime Medicine, Inc. Common Stock
Ticker PRME
Market Cap $358.43M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $3.70
List Date Oct 20, 2022
Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Website Open Company Website